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The investigation of patterns of change in psychological 
treatments has recently emerged as a topic in the research literature. 
Most treatment concepts and protocols so far have the implicit 
assumption of a linear or log-linear change course as the common 
pattern for all patients (e.g., Howard, Kopta, Krause, & Orlinsky, 
1986; Lambert, Hansen, & Finch, 2001). However, interindividual 
differences in change over the course of the treatment might reflect 
different mechanisms and processes of change (Kazdin, 2007). 
Furthermore, knowledge about differences in change profiles might 
enable researchers and clinicians to maximize treatment outcomes for 
individual patients (Barlow, 2010; Lambert, 2007; Lutz, 2002). 
Therefore, research on early change is not only related to the debate 
on the optimal “dosage” of therapy. It is also an important issue 
related to the growing interest in routine outcome monitoring and 
practice-oriented research (Castonguay, Barkham, Lutz, & McAleavy, 
2013; Lambert, 2013; Newnham & Page, 2010; Shimokawa, Lambert, 
& Smart, 2010). However, to enable therapists to derive decisions 
about patients’ improvement or nonimprovement from feedback 
information, rules based on scientific considerations and empirical 
tests are necessary. 
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Different methods and criteria for the definition of such decision 
rules have been proposed (e.g., Lambert et al., 2002; Lutz, Stulz, 
Martinovich, Leon, & Saunders, 2009). These different concepts can be 
broadly classified into two general classes: (a) those that take 
information from two time point assessments into account and (b) 
those that are able to consider information from the whole treatment 
course. 
Decision rules based on only two assessments are relatively 
simple comparisons between impairment scores on a certain 
instrument for two time points. These rules define how large the 
difference between these scores has to be to consider that change 
improvement or deterioration. These definitions could, for example, 
rely on a priori–defined expert judgments about good and poor 
treatment progress. Regularly, these judgments rely on the 
psychometric properties of an instrument in different reference 
samples. These properties guide the decision on how much change 
must have been achieved, given a certain intake score, to consider a 
treatment successful, unhelpful, or even harmful. An often-applied 
method of this kind is the concept of clinically significant change 
introduced by Jacobson, Follette, and Revenstorf (1984) and extended 
Jacobson and Truax (1991). In this approach, to be considered 
clinically significantly improved from Time Point 1 to Time Point 2, 
patients’ scores on an instrument have to meet two criteria: (a) the 
scores have to move from a range that is more probable for a sample 
of clinically impaired patients into a range that is more probable for a 
nonclinical reference sample, and (b) the difference between the 
scores has to be statistically significant and, thus, not just a result of 
imprecise measurements. If only the second criterion is met, an 
observed improvement is evaluated as reliable (i.e., statistically 
significantly different from zero) but not clinically significant, because 
the impairment score after the treatment is still highly probable for 
impaired reference samples. This concept of clinically significant 
change has great appeal to practitioners, because it can easily be 
applied in everyday clinical practice. 
In comparison, decision rules taking into account the entirety of 
change course information are, for example, based on statistically 
derived response predictions based on repeated assessments of 
already treated patients. With the growing availability of large datasets 
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including repeated measurements over the course of treatment and 
the growing capacity of computers, sophisticated approaches based on 
intensive longitudinal methods have been more often developed. 
Modern statistical tools of growth curve modeling have been applied to 
generate expected treatment response (ETR) curves. These predictions 
can be compared with the actual change course of a patient (e.g., 
Finch, Lambert, & Schaalje, 2001; Lutz et al., 2005). On this basis, 
treatment response patterns can be detected. Specifically, growth 
mixture modeling (GMM) has been demonstrated to be useful for the 
identification of early change patterns (e.g., Cuijpers, van Lier, van 
Straten, & Donker, 2005; Lutz et al., 2014; Rubel, Lutz, & Schulte, 
2013; Stulz, Lutz, Leach, Lucock, & Barkham, 2007). GMM is a latent 
variable cluster analytic method. This method allows the categorization 
of patients into classes with shared treatment response over a defined 
time period (Nagin & Odgers, 2010). 
Both of the just-described methods have been used to identify 
early change patterns, support therapists in the evaluation of their 
patients’ treatment progress, and guide them to adapt their treatment 
planning accordingly (e.g., Lutz, Böhnke, Köck, 2011). 
Several studies have identified subgroups of clients showing 
substantial improvements early in treatment. Most of these studies 
suggest that these fast-responding patients are able to maintain their 
initial success in that they show markedly positive outcomes (e.g., 
Haas, Hill, Lambert & Morrell, 2002; Lutz et al., 2014; Lutz, Stulz, & 
Köck, 2009). Despite the observation of early positively responding 
patients in different studies, there is no consistent definition of the 
phenomenon of “early positive response.” For example, Stewart et al. 
(1998) operationalized it as psychopathology being absent or minimal 
after 2 weeks of treatment. Other studies used a minimum percentage 
of improvement in the relevant outcome measure to identify early 
positively responding patients (Hayes et al., 2007; Renaud et al., 
1998). Again, others used ETR curves to define early positive change 
by comparing these predictions with the actual session-to-session 
ratings of patients’ symptomatology (Haas et al., 2002; Leon, Kopta, 
Howard, & Lutz, 1999). In summary, definitions of early positive 
response have been dependent on the researchers’ divergent 
judgments on the essential aspects of this construct. 
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Recently, GMM has been repeatedly used for the investigation of 
patterns of early change in psychotherapy, and it has consistently 
revealed a pattern of early improving patients (e.g., Lutz et al., 2014). 
However, GMM is a rather complex statistical method with 
computationally demanding model-estimating algorithms. Given that, 
an important question not yet answered is whether GMM-identified 
early positive responders are a more informative subgroup than those 
identified with less complex change evaluations (e.g., clinically 
significant change). The aim of this study was to compare the concept 
of clinically significant change (Jacobson & Truax, 1991) with a GMM-
based approach regarding their shared and distinct characteristics for 
the identification of early positive treatment response. Consequently, 
the following research questions were addressed in this study: First, 
how are the differentially identified early positive response groups 
related to each other regarding the following variables?: number of 
patients identified, overlap of subgroups, intake impairment, therapy 
outcome, and therapy length. Second, how stable are the differentially 
identified early improvements in the course of the treatment? Third, is 
the more complex GMM approach more advantageous than simple 
clinically significant change criteria in terms of specificity and 
sensitivity for the detection of early positive responders who also show 
positive treatment outcomes? 
Method 
 
Patients 
The complete study sample consisted of 5,484 patients treated 
between June 2006 and December 2011 for at least four sessions in 26 
centers comprising 20 college counseling centers, four primary care 
medical centers, and two private mental health centers. A written 
informed consent to allow for the anonymous use of their data in 
research projects was given by clients prior to their first assessment. 
Patients were treated for different psychological problems, 
predominantly symptoms of depression and anxiety. The majority of 
patients were female (61.7%; 3.6% did not report), and all of them 
were 18 years of age or older. Most of the patients who gave 
information about their racial background described themselves as 
European American (40.7%). The further distribution of patients’ 
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ethnicity was as follows: Asian American (4.1%), African American 
(3.7%), Latino/Hispanic (3%), Native American (0.5%), multiracial 
(0.4%), and other (7.9%; 39.7% did not report). Regarding 
relationship status, 41.7% indicated that they were single, 16.7% 
dating, 7.5% married, 1.5% separated, and 0.7% divorced (31.9% did 
not report). 
Most of the patients (3,894; 71%) started treatment with global 
mental health (GMH) scores in the range of a clinically impaired 
reference sample with regard to the cutoff criterion c described by 
Jacobson et al. (1984) and Jacobson and Truax (1991). 
Therapists and Treatment 
Two hundred and forty therapists from different professional 
backgrounds (including psychologists, psychiatrists, clinical social 
workers, and trainees) provided the treatments. Therapists were 
predominantly female (65.8%; 8% did not report) and European 
American (64.6%; 18.3% did not report). Regarding degrees, most of 
the therapists had a master’s (46.7%) or a doctorate (29.2%; 8.8% 
did not report). There was no requirement for therapists to follow a 
manualized treatment protocol. Treatment duration was not fixed to a 
strict time limit and varied between four and 109 sessions (M = 9.76, 
SD = 8.25, Mdn = 7.00). 
Measures 
Prior to each session, the Behavioral Health Measure–20 (BHM-
20; Kopta & Lowry, 2002) was administered via a computer-based 
system, the CelestHealth System-MH (Bryan, Kopta, & Lowes, 2012). 
The BHM-20 is a 20-item self-report measure consisting of three scales 
that cover the proposed phases of psychotherapy outcome (Howard, 
Lueger, Maling, & Martinovich, 1993): well-being (three items), 
symptoms (13 items), and life functioning (four items). Respondents 
are asked to rate the items regarding how they have been feeling over 
the past 2 weeks on a Likert-type scale ranging from 0 (extreme 
distress/poor functioning) to 4 (no distress/excellent functioning). A 
GMH score is calculated by adding the scores for all 20 items and 
dividing this sum by the number of endorsed items. High scores in the 
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GMH indicate good psychological functioning. The internal consistency 
reported for GMH in a larger sample from which the present study 
sample is a subsample was reported as α = .91 (Stulz, Lutz, Kopta, 
Minami, & Saunders, 2013). A test–retest reliability for a 2-week 
interval between tests in a college student sample was reported as rtt 
= .80. With regard to discriminant validity, the instrument showed the 
ability to distinguish clinical from nonclinical groups. Concurrent 
validity was shown by high correlations between the GMH scale and 
other established measures, including the Outcome Questionnaire–45 
(Lambert & Finch, 1999) and the Symptom Checklist–R–90 (Derogatis 
& Savitz, 1999), with rs = −.81 and −.85, respectively. 
Data Analysis 
Early positive response. As described earlier, the definition of 
early positive response varies considerably between studies. Besides 
the applied methods, the time criterion is also subject to this variation. 
As a consequence, there is no agreed upon time span that is 
universally defined as “early” in psychotherapy research. For the 
present study, we chose the time criterion taking into account clinical 
and methodological considerations. Obviously, clinicians need to take 
decisions right from the start of the treatment and continuously 
throughout its course. It has been repeatedly shown that decisions 
based on statistical predictions are at least equal to and often better 
than decisions based solely on clinical judgment (e.g., Grove, Zald, 
Lebow, Snitz, & Nelson, 2000; Meehl, 1954). Thus, from a clinical 
perspective, it is important to design decision rules that support 
clinicians in their decision-making process as early in the treatment as 
possible. 
Methodologically however, GMM as a latent growth model needs 
at least three scores to model a log-linear trend that was repeatedly 
reported for individual change curves in the research literature (e.g., 
Stulz et al., 2013). Consequently, we decided to define the time span 
until the third assessment (session) as “early.” This is the earliest time 
point that allows for modeling of a log-linear change trend. Application 
of this rationale resulted in a time criterion that was the same as the 
one chosen by Haas et al. (2002). 
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GMM. First, the assumption of a log-linear relationship between 
the amount of treatment and outcome was tested comparing an 
intercept-only, a linear, and a log-linear latent growth model. A log-
linear (i.e., a negatively accelerated) association between number of 
sessions and change corresponds to the assumptions of the dose-
response model (Howard et al., 1986), which is widely used in 
psychotherapy research (Kopta & Lowry, 2002). In the next step, 
typical patterns of early change in the GMH scores over the first three 
sessions were identified using GMM. This method enables the 
identification of unobserved groups of individuals with shared patterns 
of change over time in one or more outcome variables (Muthén, 
2004). It is based on conventional latent growth models (LGMs) but 
relaxes (i.e., does not adhere to) the assumption that all individuals in 
a sample need to be drawn from a single population. Instead, by 
implementing a categorical latent variable into the LGM framework, 
GMM allows the identification of subpopulations (latent classes) of 
individuals that correspond to different shapes of growth curves. In 
GMM, the mean growth curves for each latent class as well as the 
individual variations around these growth curves in terms of growth 
factor variances are estimated. In this current application, a model 
was chosen for which variances around the class-specific slopes were 
fixed to zero within classes, whereas intercept variances were freely 
estimated but constrained to be constant between classes. 
Consequently, all differences in change over time had to be captured 
completely by the differences in mean slopes of different latent 
classes. This model was stable and emphasized the identification of 
heterogeneity in change over time. 
In this study, GMMs were estimated using the Mplus software 
(Version 6.0; Muthén & Muthén, 2010). Mplus uses maximum 
likelihood estimates as well as an accelerated expectation 
maximization procedure and allows for the estimation of models with 
missing values in continuous outcome variables. 
Prior research applying GMM to session-by-session 
psychotherapy data has repeatedly identified a subgroup of patients 
who start treatment highly impaired and improve in the first few 
sessions. Patients showing such a pattern are, in the following, 
referred to as GMM—early positive change. 
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Clinically significant change criteria. Patient change was 
additionally assessed using the concept of clinically significant change 
(Jacobson & Truax, 1991). This concept is composed of two conditions. 
The first condition to consider the change of a patient clinically 
significant is reliable improvement. A patient changed reliably (i.e., 
statistically significantly; p < .05) if the difference between the two 
scores is larger than the reliable change index (RCI) of the instrument. 
The second condition is the movement of the scores from the range 
that is more likely for a clinical reference sample into the range that is 
more likely for a nonclinical reference sample (crossed cutoff). For the 
comparison with the GMM-based approach, reliable improvement and 
clinically significant improvement are investigated as two separate 
methods. On the basis of their GMH scores from the first to the third 
session, patients were categorized in one of two groups: (a) clinically 
significant improvement, with the GMH score moving from a score 
below 2.92 (cutoff) before the first session to a score above 2.92 
before the third session and the difference between these two scores 
being larger than 0.39 points (RCI), or (b) reliable improvement, with 
the difference between the first score and the third score being larger 
than 0.39 points but the cutoff value of 2.92 not being crossed. 
For the evaluation of treatment outcome, the difference 
between the first and the last score is assessed using the same 
criteria. Two additional groups for the description of negative 
treatment outcomes were defined: (c) no change, with the difference 
between the first score and the last score being smaller than 0.39 
points and (d) deterioration, with the difference between the first score 
and the last score being larger than 0.39 points but in the negative 
direction. 
Results 
 
Reliable and Clinically Significant Improvement 
At Session 3, 1,918 (35.0%) out of the 5,484 patients met the 
criterion of reliable improvement. Eight hundred and ninety-two 
patients (16.3%) had achieved clinically significant improvement until 
Session 3, whereas 3,035 patients (55.3%) showed no statistically 
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reliable change from the first to the third session, and 531 (9.7%) had 
deteriorated until Session 3. 
Early Change Patterns (GMM) 
The Bayes information criterion (BIC; Schwartz, 1978) indicated 
the best fit for a log-linear model: intercept-only Model 111,923.96, 
linear Model 110,806.38, and log-linear Model 110,733.71. 
Accordingly, the subsequent growth mixture analyses assumed a log-
linear relationship between the number of treatment sessions and 
outcome. 
In the following analyses, the number of distinct patterns of 
early change was determined by means of GMM (Muthén, 2004). 
Starting with one latent class (i.e., with a conventional LGM), 
additional classes were entered into the GMM until the optimal number 
of latent classes was found. The decision on the number of latent 
classes was based on joint consideration of two typically applied 
indices. The BIC (Schwartz, 1978) steadily decreased from the one- 
through the seven-class solutions (21,742.17; 21,532.58; 21,318.14; 
21,220.09; 21,116.84; 21,069.74; and 21,052.47), indicating a model 
with at least seven classes having the best fit. In comparison, the Lo–
Mendell–Rubin likelihood ratio test of model fit (Lo, Mendell, & Rubin, 
2001) showed that already the addition of a fifth class did not result in 
a significant improvement of model fit (three classes vs. four classes: 
p < .01; four classes vs. five classes: p = .08). Consequently, a model 
with four classes (see Figure 1) was considered the best solution and 
used for further analyses. 
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Figure 1. Estimated mean change trajectories over the first three sessions for a four-
class growth mixture model solution. 
The first subgroup comprised of 396 patients (7.2%) who 
started treatment with a relatively high average impairment (intake 
GMH score: M = 1.80, SD = 0.41) and improved relatively quickly until 
Session 3. Patients categorized in this group showed early positive 
response according to the GMM approach and constitute the GMM—
early positive change group, as specified earlier. The second subgroup 
comprised of 1,518 patients (27.7%) who also started treatment 
relatively highly impaired (intake GMH score: M = 1.92, SD = 0.35) 
but improved relatively slowly until the third session. Both of these 
first two subgroups started treatment substantively more impaired 
than an average patient from a counseling (M = 2.68) and outpatient 
psychotherapy (M = 2.33) reference sample (Kopta & Lowry, 2002). 
The third subgroup was by far the largest, comprising 3,440 patients 
(62.7%). This class included patients who started with a relatively low 
initial impairment (intake GMH score: M = 2.89, SD = 0.42) and 
showed rather slow improvement until Session 3. The fourth subgroup 
comprised of a small number of patients deteriorating during the first 
three assessments (n = 130; 2.4%). The mean intake GMH score of 
the fourth subgroup was 2.92 (SD = 0.43). Comparing the initial 
impairment of Subgroups 3 and 4 with counseling and psychotherapy 
reference samples reveals that these subgroups started with 
comparatively low levels of impairment (Kopta & Lowry, 2002). 
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Overlap Among the Three Definitions of Early Positive 
Response 
In a next step, the overlap and uniqueness of the differentially 
identified early positive response groups were investigated. The overall 
numbers and the overlap between the three groups, with percentages 
given in reference to each overall number, are displayed in Table 1. 
 
Numbers of Patients in the Differentially Identified Early Positive-Response Groups and 
Their Overlaps at Session 3 
Overall, the GMM approach identified many fewer patients as 
early positive responders than did the reliable improvement (about five 
times fewer) and clinically significant improvement (about two times 
fewer) criteria. However, considering the different group sizes, the 
three groups were largely overlapping (see Table 1). All patients in the 
GMM—early positive change group also improved reliably from intake 
to Session 3 (N = 396; 100%). Clinically significantly improved 
patients were 253 (64%) of these GMM—early positive change 
patients. Because of the overall group size differences, these numbers 
correspond to only 21% of reliably improved patients who were also 
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identified via the GMM approach and to 28% of clinically significantly 
improved patients. 
Relations to Treatment Length, Intake Impairment, and 
Treatment Outcome 
The three groups of early positively responding patients 
identified via different methods were compared with regard to 
treatment length, intake impairment, and treatment outcome. In 
terms of number of sessions in treatment, the three groups did not 
differ significantly (see Figure 2) from each other (GMM—early positive 
change: M = 8.32, SE = 0.41; reliably improved: M = 8.93, SE = 
0.37; clinically significantly improved: M = 8.57, SE = 0.44). With 
regard to initial impairment, patients with early positive response 
identified via GMM (M = 1.79, SE = 0.03) started with lower GMH 
scores (indicating higher impairment) than early improving patients 
identified with the two other methods (reliable improvement: M = 
2.10, SE = 0.03; clinically significant improvement: M = 2.38, SE = 
0.03). The GMM—early positive change group also showed by far the 
highest pre- minus posttreatment differences (high values indicating 
large positive changes from pretreatment to posttreatment) in GMH 
scores (M = 1.28, SE = 0.03; reliably improved: M = 0.93, SE = 0.03; 
clinically significant improved: M = 0.85, SE = 0.04). 
 
Figure 2. Mean numbers of sessions, mean intake general mental health (GMH) 
scores, mean differences between pre- and posttreatment GMH scores (high values 
indicating high positive changes from pretreatment to posttreatment), and 95% 
confidence intervals for each of the early positive response groups and the complete 
sample. 
A more fine-grained examination of the relations among 
treatment outcome, early change, and therapy length is depicted in 
Table 2, which shows, the pre–post effect sizes (ds) and categorized 
change statuses after treatment (reliably improved, clinically 
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significantly improved, no change, and deterioration) for the three 
early positive change groups, depending on the number of sessions 
attended and in total. Irrespective of the number of sessions attended, 
the GMM—early positive change group showed the highest pre–post 
effect sizes (ds = 1.88–2.16) as well as the highest shares of reliably 
improved patients after the treatment (90%–93%). In comparison, the 
groups of patients identified via clinically significant change methods 
both showed smaller yet also high effects sizes (both between about 
1.15 and 1.36) and shares of reliably improved patients at the end of 
the treatment (both between 74% and 82%). Regarding clinically 
significant change after the treatment, the GMM—early positive change 
group and the group of patients who had improved clinically 
significantly at Session 3 showed similar shares (both in the 65%–73% 
range). In comparison, a little less of the early reliably improved group 
achieved clinically significant change until the end of the treatment 
(51%–53%). The numbers of patients who showed no change or 
deterioration from pre- to post-treatment were slightly smaller in the 
GMM—early positive change group than in the groups defined via 
reliable and clinically significant change criteria. 
 
Frequencies and Final Treatment Outcomes (ds and Categories) for All Patients and for 
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Those Meeting the Respective Early Positive Response Criteria (Status After Session 3) 
Depending on Treatment Length and in Total 
Compared with the effect sizes for each of the three early 
positive response groups, the average effect sizes for all patients in 
the sample were consistently smaller (between 0.62 and 0.75). On 
average, effect sizes for all patients were about half as high as those 
of the groups defined with clinically significant change criteria and one-
third as high as the GMM-defined group. Accordingly, although the 
rates of reliably and clinically significantly improved patients at the end 
of the treatment were much lower (between 28% and 35% and 
between 12% and 18%, respectively) the rates of patients showing no 
change or deterioration over the course of the treatment were much 
higher (between 55% and 64% and between 9% and 11%, 
respectively). 
To evaluate the predictive power of the different approaches for 
final treatment status, specificity and sensitivity values were 
calculated, and these are presented in Table 3. Although the GMM—
early positive change group showed the highest specificities for 
predicting positive reliable change (0.989) and clinically significant 
change (0.964) from pre- to posttreatment, its sensitivities were the 
lowest for both outcome criteria (.135 for reliable and .157 for 
clinically significant improvement). Similarly, high specificity values for 
the prediction of reliable and clinically significant improvement were 
found for the early positive responders classified via clinically 
significant change criteria (.933 for both reliable and clinically 
significant improvement). Sensitivity values for this subgroup were 
higher but still low (.260 for reliable and .386 for clinically significant 
change). The highest sensitivity values were obtained for the reliable 
early improvement criterion (.559 for reliable .599 for clinically 
significant improvement). Conversely, specificity values were the 
lowest for this subgroup of early positive responders identified via 
reliable change (.856 for reliable and .757 for clinically significant 
improvement). 
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Specificity and Sensitivity Values of the Three Classification Methods for the Prediction 
of Positive Reliable Change and Clinically Significant Change After Treatment 
Stability of early improvements given the differential definition 
methods is illustrated in Figure 3, which shows the percentages of 
reliably improved patients after each of Sessions 4 through 13 and at 
the end of the treatment. Independent of session number, the rate of 
reliably improved patients was consistently highest in the GMM—early 
positive change group (about 90%). Only slight fluctuations could be 
observed over the course of the first 13 sessions. The rates for the two 
early improving groups defined with the clinically significant change 
criteria were similar to each other and consistently smaller than those 
for the GMM-defined group. 
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Figure 3. Percentages of reliably improved patients after Sessions 4–13 and after the 
end of the treatment for 5-patient subgroups defined on the basis of their change 
status after Session 3. 
Discussion 
 
In this study, three methods for the identification of early 
positive response to psychotherapy were compared with regard to 
overlap and uniqueness of the identified subgroups and their specific 
characteristics and predictive qualities. A GMM-based approach was 
compared with two methods from the concept of clinically significant 
change. Given the methodological definitions of the clinically significant 
change methods and GMM, there are some general differences, which 
can be deduced on a theoretical basis: Whereas for the clinically 
significant change methods, an a priori fixed amount of change is 
minimally required to meet one of the criteria (RCI), GMM is more 
flexible in this regard. How much change is needed to be identified by 
the GMM approach depends on the nature of the change courses within 
the whole patient sample and all of the available change course 
information. GMM is also more flexible with regard to intake and end 
state functioning. To be categorized as clinically significantly improved, 
a patient’s score has to move from the range above an a priori defined 
cutoff score into the range below that cutoff score. Consequently, 
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patients who do not start the treatment within the range above the 
cutoff score can never improve “clinically significantly.” As for the GMM 
approach, there are no such cutoff scores. Given that, theoretically 
every patient can be categorized as belonging to the improved group. 
Another important difference is the fact that the GMM approach takes 
into account the complete change course until a certain time point. 
Clinically significant change criteria, conversely, solely rely on the 
comparison of change from one time point to another. 
The aim of this study was to compare these three methods for 
the identification of early positive response to psychotherapy on an 
empirical basis. For this purpose, these methods were applied to the 
first three scores of patients in a big naturalistic outpatient 
psychotherapy sample. The results of the comparison of the three 
methods provide evidence that the different identification methods 
have very specific characteristics when defining similar patients as 
early positive responders. In fact, all of the early positive responders 
identified via GMM were also detected by the reliable improvement 
method. Given that, the GMM—early positive change group was a 
subgroup of the patients reaching positive reliable change until Session 
3. However, GMM categorized about five (positive reliable change) and 
two (clinically significant change) times fewer patients as early positive 
responders than did the other methods. Consequently, the GMM 
approach is more conservative in its identification of early positively 
changing patients than are clinically significant change methods. 
Further, it could be shown that the GMM—early positive change 
group was characterized by higher average intake impairments and 
larger average pre- to posttreatment changes than the groups 
identified via clinically significant change criteria. As high intake scores 
are regularly connected to higher pre- to posttreatment changes, 
these results suggest that the difference between the early positive 
responders identified with the GMM approach and those defined via 
reliable change until Session 3 was mainly attributable to high intake 
values. As a consequence, one could argue that the GMM model is 
unnecessary if the amount of change from intake to Session 3 and the 
intake score are known. To test this hypothesis, a binomial logistic 
regression analysis was conducted. Being classified as an early positive 
responder with the GMM method (yes = 1, no = 0) was used as 
categorical dependent variable; changing reliably positively until 
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Session 3 (yes = 1, no = 0) and the pretreatment GMH score were 
used as predictor variables in the regression analysis. Only 78 (19.7%) 
of the 396 early change patients identified via GMM were correctly 
predicted by the logistic regression model using these predictor 
variables. Given that, GMM-identified early positive responders were 
not just a subgroup of reliably improved patients with very low intake 
scores (high intake impairment). Thus, the application of GMM for the 
identification of early positively responding patients supplies additional 
information that cannot be deduced alone from the intake score and 
the amount of change until Session 3. This might be due to the fact 
that GMM does not use only the information from two time points 
(Session 1 and Session 3). Because GMM takes each of the repeated 
assessments of individual change curves into account, this definition 
generally requires a more stable positive response pattern than do the 
clinically significant change criteria. There might be many patients 
starting with high initial impairment and changing reliably or even 
clinically significantly from the first to the third session but not 
meeting the GMM criteria because the score in the second session was 
not positive enough. This aspect is more pronounced the more 
assessments that are considered. In the case of the present study, in 
which only three assessments were taken into account also, rather 
instable change courses could result in an average early response 
pattern if the gain from the second to the third session was big 
enough. 
With respect to outcome prediction, which is the basis for the 
formulation of decision rules, it could be shown that both the GMM 
approach and the computationally less demanding clinically significant 
change methods had their positive and negative aspects. Being 
identified as an early positive responder by the GMM approach was a 
highly reliable prognostic factor for being reliably improved after the 
treatment. However, this method showed itself to be very insensitive. 
As a consequence, many patients who improved reliably or clinically 
significantly from pre- to posttreatment would have been missed if 
only GMM had been applied. 
Given their ease of use, it comes as somewhat of a surprise that 
clinically significant change criteria showed such a good performance 
in predicting ultimate treatment outcome. While being only slightly 
less specific than GMM in the prediction of treatment success, the 
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reliable improvement method in particular proved to be much more 
sensitive than the more complex GMM approach. 
Given that, decision rules should not solely rely on GMM. Rather 
GMM-based approaches should be complemented by more sensitive 
reliable and clinically significant change methods. In practice, such an 
integrated approach could be implemented in feedback software tools 
by the means of a stepwise system with different probability estimates 
for positive outcomes depending on the method that classified a 
patient as an early positive responder. 
However, one of the limitations of the present study concerns 
the results of the comparison of the methods regarding their predictive 
qualities for treatment outcome. One of the three compared methods 
is also used to assess treatment outcome. We chose the clinically 
significant change criteria for the evaluation of treatment outcome 
(see Tables 2 and 3) because they are widely used methods in clinical 
research and practice (cf. Ronk, Korman, Hooke, & Page, 2013). It 
should be noted that the predictive power of a method is regularly 
relatively high if it is used to define a state at two time points and the 
latter state is predicted from the first state. Compared with that, the 
predictive power is lower when two different methods are used to 
define the states at the two respective time points. Accordingly, 
because the reliable and clinically significant change criteria are more 
similar to each other than to the GMM approach, the present results 
might be biased to the disadvantage of GMM. Future investigations 
should consider evaluating the different methods by using a different 
instrument for the evaluation of treatment outcome than the one used 
here for the assessment of early positive change. 
In addition, the generalizability of these results is reduced 
because only patients with at least four sessions were included in the 
analysis. Given that, the present results are only valid for patients who 
do not drop out before the fourth session. However, previous studies 
have shown that some patients experience substantial improvements 
in the first or first two sessions (Haas et al., 2002). Thus, there might 
be some early improving patients who were excluded from the current 
analysis because of a too early termination of the treatment. 
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Another shortcoming of the present study regards the definition 
of early, which is always a matter of debate and is related to 
theoretical orientations, national health care policies, and the actual 
number of sessions attended by each individual patient. It follows from 
that that, for patients being provided with 300 sessions of therapy, the 
early phase might rather be the first 30 sessions instead of the first 
three. But for patients who were provided with four sessions, the first 
three also cannot be doubtlessly defined as “early.” Owing to these 
considerable differences, it simply would not be possible to define an 
early treatment phase that would be appropriate from all perspectives. 
Consequently, this definition has to be done on grounds of the specific 
characteristics of the investigated patient sample. In the current 
investigation, we decided to define as early the shortest possible time 
span that still enabled us to estimate a log-linear change trend with 
the GMM approach. Although Haas et al. (2002) chose the same 
interval, compared with most other investigations of early response, 
the first three assessments represents a rather short phase. In 
addition to the just-stated rationale, several other reasons support our 
decision to reduce the time span to this minimum. First, the 
treatments in this sample were rather short (M = 9.76 sessions). Thus, 
our early phase definition already covered, on average, about one-
third of the complete treatment. In addition, the number of patients 
that could be taken into account was at its maximum when the 
required number of sessions was minimal. Thus, this approach enabled 
us to derive predictions for about 20% more patients than we could 
have if we had extended the early phase to Session 4 and 34% more 
patients than we could have if we had extended the early phase to 
Session 5. However, utility for clinical practice was the most important 
argument for choosing the shortest possible phase. Decision rules are 
designed to assist clinicians in their decision making. Therefore, it 
should be the aim of researchers to design decision rules so that they 
can be validly applied as early in treatment as possible. 
It must also be admitted that a potential alternative explanation 
of early positive response in psychotherapy outcome studies is 
regression to the mean. Statistically, patients who start treatment 
rather highly impaired have more room to improve in their scores than 
do patients who start with relatively low impairment. For the present 
sample, this is also reflected in the significant negative correlation 
between the initial score and the change score from pre- to 
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posttreatment (r = −.53, p = <.00). In such cases, when the 
correlation between initial scores and amount of change is negative, 
the occurrence of regression to the mean is likely (Rogosa, Brandt, & 
Zimowski, 1982; Speer, 1992). The common clinically significant 
change concept introduced by Jacobson and Truax (1991), which was 
applied in the current study, does not take regression to the mean into 
account. Speer revisited the concept and presented a method that 
considers regression to the mean as being more conservative for more 
impaired patients (more distant from the mean). Therefore, all early 
change classes were additionally checked with this more conservative 
method proposed by Speer. All of the patients who were defined as 
early positive responder by the Jacobson and Truax method or by the 
GMM method also improved statistically significant (p < .05) according 
to the Speer method. Thus, it is unlikely that regression to the mean 
was the only factor that led to early positive improvements. 
Despite these limitations, the current study may have potential 
implications for future research, health care services, and clinical 
practice. Considering the results of the current study, future research 
on early response might be better able to anticipate the implications 
connected with the different methods. For the evaluation of 
correlations between early response and treatment outcome, it is of 
central importance to know which methods were applied for the 
definition of early positive response and how specific and sensitive 
they are. However, replications in other samples, settings, and 
countries as well as with different instruments are needed to validate 
and generalize our results. Given the high rates of patients from the 
early positive response groups who showed positive ultimate 
treatment outcomes, psychometric progress monitoring and feedback 
seem to be important tools for health services to optimize the 
allocation of resources (i.e., treatment sessions). Patients who show 
positive response at such an early stage of the treatment might need 
fewer sessions than patients who need longer to show positive 
response (cf. Lambert, 2007). However, to deduce concrete 
suggestions for health care services, controlled clinical trials with 
follow-up assessments would be necessary to test the hypothesis that 
patients who improve early need fewer sessions to achieve stable 
positive outcomes than do more slowly improving patients. Regarding 
the design of feedback software systems, results suggest a 
combination of the different approaches. Whereas early positive 
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responders identified via clinically significant change criteria had very 
high chances of a good treatment outcome, additional GMM-based 
information could supply additional assurance to therapists. 
An important message for practitioners who will not or cannot 
use sophisticated feedback software is the very good performance of 
the clinically significant change criteria for the prediction of ultimate 
treatment outcome. Given the high predictive qualities of these easy-
to-apply methods, the RCI and the cutoff score of an instrument 
should be mandatory information in every test handbook. Being 
provided with this information enables every therapist who tracks his 
or her patients’ progress session by session to evaluate the chances 
for positive treatment outcome. Using the instrument from the present 
study in a similar sample, a therapist could also directly apply the 
findings from the present study. Therapists know, for example, that if 
one of their patients improves reliably until Session 3, the probability 
for this patient to be reliably or clinically significantly improved at the 
end of the treatment is more than doubled (from 33.6% to 79.1% for 
reliable and from 18.5% to 51.4% for clinically significant change). 
Taken together, the findings of the present study illustrate the 
specific characteristics of three widely used approaches for the 
identification of early positive response in a large sample of 
psychotherapy outpatients. The findings underline not only the 
additional value provided by the computationally demanding GMM 
approach but also the surprisingly good validity of predictions that can 
be deduced on the grounds of simple clinically significant change 
criteria. For routine outcome monitoring and feedback systems, the 
results suggest that a combination of decision rules, a GMM-based 
approach, and clinically significant change methods might be a fruitful 
combination. 
Footnotes  
1 Criterion c defines the cutoff point as the point that lies halfway 
between the mean of a functional and a dysfunctional population if 
variances are equal. Considering the means and standard deviations 
reported for the GMH score of the Behavioral Health Measure–20 in 
Kopta and Lowry (2002), cutoffGMH is calculated as follows (Jacobson 
et al., 1984; Jacobson & Truax, 1991):  
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where M0/s0 and M1/s1 are the mean/standard deviations of a 
community adult reference sample and a sample of psychotherapy 
outpatients, respectively. This criterion resulted in a cutoffGMH score 
of 2.92. Thus, patients with a GMH score below 2.92 are more likely (p 
< .05) to belong to a clinical population than to a nonclinical 
population. 
2 The RCI is calculated using the following formula (Jacobson & Truax, 
1991):   where SD is the standard 
deviation of the GMH score in a community adult sample (Kopta & 
Lowry, 2002), and r is the reliability (internal consistency; α = .91) of 
the instrument in a similar sample (Stulz et al., 2013). Internal 
consistency, instead of test–retest reliability, is used to calculate the 
RCI. Internal consistency has been recommended for clinical samples 
because test–retest reliabilities are likely to be deflated by real 
individual differences in treatment response and phenomena like 
spontaneous remission (Martinovich, Saunders, & Howard, 1996). 
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